SOURCE: Equity News Circuit

Equity News Circuit

December 20, 2012 09:00 ET

Top Stock Movers: B.O.S. Better Online Solutions Ltd. (NASDAQ: BOSC), Suntech Power Holdings Co. Ltd (NYSE: STP), LDK Solar Co., Ltd. (NYSE: LDK), Oncothyreon Inc. (NASDAQ: ONTY).

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwire - Dec 20, 2012) - B.O.S. Better Online Solutions Ltd. (NASDAQ: BOSC), Suntech Power Holdings Co. Ltd (NYSE: STP), LDK Solar Co., Ltd. (NYSE: LDK), Oncothyreon Inc. (NASDAQ: ONTY).

B.O.S. Better Online Solutions Ltd. (BOSC) was the biggest winner on Wall St. during Wednesday's trading session. Shares gained $3.47 or 73.52% to close the day at $8.19 on volume of 475,008 shares traded. Last Friday, a 1-4 share reverse split took effect & the company has gained over 215% since. Will the rally continue or will we start to see a decline? Find out in our exclusive report at:

Suntech Power Holdings Co. Ltd. (STP) was another big gainer seeing shares rise 17.76% to close the day at $1.26 on nearly 9 million shares traded on news overnight from China. "In a statement late Wednesday, the State Council, China's cabinet, said it would reform the industry, such as by encouraging mergers and acquisitions," writes Wayne Ma in the WSJ. "The cabinet will reduce government support and ban local governments from supporting failing domestic solar companies, it said." Will this positive news lead to further gains ahead this week? Find out more in our exclusive report at:

LDK Solar Co., Ltd. (LDK) was another stock seeing gains during yesterday's trading session joining the solar sector rally based on the positive news overnight out of China. The company saw shares rise 13.49% to close at $1.43 on volume of 4.7 million shares traded. Find out if the stock will continue to rise or if it's time for it to cool off in our exclusive report at:

Oncothyreon Inc. (ONTY) saw shares decline 51.33% to close yesterday at $2.19 as the company announced that the pivotal Phase 3 clinical trial of L-BLP25 (formerly referred to as Stimuvax) known as START did not meet its primary endpoint of an improvement in overall survival in patients with unresectable, locally advanced stage IIIA or stage IIIB non-small cell lung cancer. The trial was conducted by Merck Serono, a division of Merck KGaA, under a license agreement with Oncothyreon. Despite not meeting the primary endpoint, notable treatment effects were seen for L-BLP25 in certain subgroups. Further analyses are planned in the coming weeks to explore the potential benefit-risk profile of L-BLP25 in certain populations. Will shares begin to recover in the coming weeks? Find out in our exclusive report at:


Squawk Box Stocks offers its daily stock alerts and market content newsletter to investors looking for timely information available! Our experienced team provides you only the best stock alerts & research reports delivered to your email inbox for FREE. Our track record of providing winning alerts has won us the trust of thousands of investors worldwide. With our dedicated research team & investor database continuing to grow we have become a leading destination for the most profitable opportunities that are available in today's stock market. To receive our FREE, comprehensive newsletter, visit

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Winning Media LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information

  • Contact Information:
    Winning Media LLC
    Email Contact